Pre-earnings options volume in Adma Biologics (ADMA) is 1.5x normal with calls leading puts 13:2. Implied volatility suggests the market is anticipating a move near 13.3%, or $2.63, after results are released. Median move over the past eight quarters is 8.8%.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA: